Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatoses
Author:
Affiliation:
1. Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology Shandong First Medical University & Shandong Academy of Medical Sciences Jinan China
Publisher
Hindawi Limited
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15924
Reference91 articles.
1. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
2. T-cell subsets (Th1 versus Th2)
3. The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype Regulation
4. Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN‐gamma involves interference with IL‐1;Oriss TB;J Immunol,1997
5. IFN-γ Acts on the Airway Epithelium To Inhibit Local and Systemic Pathology in Allergic Airway Disease
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unveiling the value of C‐reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross‐sectional study;Experimental Dermatology;2024-07-29
2. Pharmacotherapy for Keloids and Hypertrophic Scars;International Journal of Molecular Sciences;2024-04-25
3. Erythema induratum of Bazin during successful treatment of atopic dermatitis with dupilumab;Australasian Journal of Dermatology;2024-02-29
4. A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency;Journal of Dermatological Treatment;2024-01-23
5. Notch signaling pathway in the development of imbalanced immune responses in patients with disseminated pulmonary tuberculosis;Bulletin of Siberian Medicine;2024-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3